DOSSIER · 13F Holders · Q2 2026

CanFite Biopharma Ltd ADR

10 institutions still hold CanFite Biopharma Ltd ADR as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 13471N409·10 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$204K
visible holders
Holders
10
filers reporting
Concentration
47.41%
CITADEL ADVISORS LLC #1
top holder share
AI Holders Summary · Q2 2026

10 institutions reported CanFite Biopharma Ltd ADR in Q2 2026. CITADEL ADVISORS LLC leads at 47.4% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
CITADEL ADVISORS LLC
CIK 0001423053
$97K33K0.00%Q2 2026
02
RHUMBLINE ADVISERS
CIK 0001115418
$52K17K0.00%Q2 2026
03
Virtu Financial LLC
CIK 0001533964· Market maker
$40K13K0.00%Q1 2026
04
GAMMA Investing LLC
CIK 0002010235
$15K7K0.00%Q3 2026
05
FIFTH THIRD BANCORP
CIK 0000035527
$4461500.00%Q2 2026
06
WELLS FARGO & COMPANY/MN
CIK 0000072971
$175590.00%Q2 2026
07
Activest Wealth Management
CIK 0001883134
$22100.00%Q3 2026
08
MORGAN STANLEY
CIK 0000895421
$310.00%Q2 2026
09
TD Waterhouse Canada Inc.
CIK 0001999606
$210.00%Q3 2026
10
Avion Wealth
CIK 0001792704
$050.00%Q1 2026